Clinical Trials Logo

Salmonella Infections clinical trials

View clinical trials related to Salmonella Infections.

Filter by:

NCT ID: NCT01608815 Completed - Clinical trials for Bacterial Infections

Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

Start date: May 2012
Phase: Phase 3
Study type: Interventional

This study is designed to assess the immunogenicity and safety of typhoid Vi polysaccharide vaccine in Japanese participants to support registration of the product in Japan. Primary Objective: To describe the seroconversion rate (percentage of subjects with at least a 4-fold increase of their Vi antibody titer) between Day 0 before vaccination and Day 28 after vaccination with typhoid Vi polysaccharide (SP093) vaccine in subjects aged 2 years and above. Secondary Objectives: - To describe the safety profile of a single dose of typhoid Vi polysaccharide vaccine up to 28 days after vaccination, in subjects aged 2 years and above. - To describe the immune response following a single dose of typhoid Vi polysaccharide vaccine in subjects aged 2 years and above.

NCT ID: NCT00177658 Completed - Clinical trials for Salmonella Infection

NCCLS Interpretive Criteria for Salmonella

Start date: March 2006
Phase:
Study type: Observational

To determine the clinical significance of gene mutations encoding antibiotic resistance, but not expressed as clinical resistance, in Salmonella bacteria

NCT ID: NCT00002052 Completed - HIV Infections Clinical Trials

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

Start date: n/a
Phase: N/A
Study type: Interventional

To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.